English Polski
Vol 24, No 1 (2018)
Case report
Published online: 2018-04-12

open access

Page views 944
Article views/downloads 938
Get Citation

Connect on Social Media

Connect on Social Media

Aorto-renal Bifurcation Stenting in a Juvenile Non-specific Aorto-Arteritis: case report

Santosh Kumar Sinha1, Vinay Krishna1, Narendra Khanna1, Lawrence Rajan2, Mukesh Jitendra Jha1, Vikas Mishra1, Mohammad Asif1, Ramesh Thakur1, Mahmadula Razi1
Acta Angiologica 2018;24(1):25-29.

Abstract

Takayasu Arteritis (TA) is a granulomatous inflammation of unknown aetiology affecting the aorta and its major branches with usual affliction among patients younger than 50 years and rarely among children. We present a 7-years old boy referred for evaluation of hypertension. He had a significant blood pressure difference between right arm, left arm and lower limbs. Computed tomography imaging of thorax and abdomen showed stenosis of left subclavian artery, left renal artery and juxtareanl aorta which was subsequently confirmed on aortogram. He underwent percutaneous endovascular therapy with aorto-renal bifurcation stenting with reduction of blood pressure and gradient. Renal angioplasty with stenting remains a challenging procedure in patients with tight ostial lesion, and juxtarenal aortic involvement in lieu of precise stent placement and avoiding side branch occlusion.

Article available in PDF format

View PDF Download PDF file

References

  1. Khanna N, Pramesti R, Sinha S, et al. Juvenile Takayasu Arteritis: A case report. Journal of Indian College of Cardiology. 2017; 7(1): 28–30.
  2. Kothari S. Takayasu's arteritis in children - a review. Images Paediatr Cardiol. 2001; 3(4): 4–23.
  3. Hahn D, Thomson PD, Kala U, et al. A review of Takayasu's arteritis in children in Gauteng, South Africa. Pediatr Nephrol. 1998; 12(8): 668–675.
  4. Tyagi S, Kaul UA, Satsangi DK, et al. Percutaneous transluminal angioplasty for renovascular hypertension in children: initial and long-term results. Pediatrics. 1997; 99(1): 44–49.
  5. US Department of Health and Human service. National Institute of Health/ National Heart, Lung, and Blood Institute. A Pocket Guide to Blood pressure Measurements in Children. NIH Publication 2007; 07-5268.
  6. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006; 65(7): 936–941.
  7. Seyahi E. Takayasu arteritis: an update. Curr Opin Rheumatol. 2017; 29(1): 51–56.
  8. Mukhtyar C, Guillevin L, Cid MC, et al. European Vasculitis Study Group. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009; 68(3): 318–323.
  9. Cheng Y, Lv N, Wang Z, et al. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol. 2013; 31(1 Suppl 75): S22–S27.
  10. Papa M, De Cobelli F, Baldissera E, et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol. 2012; 198(3): W279–W284.
  11. Schmidt WA. Imaging in vasculitis. Best Pract Res Clin Rheumatol. 2013; 27(1): 107–118.
  12. Tezuka D, Haraguchi Go, Ishihara T, et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012; 5(4): 422–429.
  13. Rao SA, Mandalam KR, Rao VR, et al. Takayasu arteritis: initial and long-term follow-up in 16 patients after percutaneous transluminal angioplasty of the descending thoracic and abdominal aorta. Radiology. 1993; 189(1): 173–179.
  14. Kim HJ, Lee CS, Kim JS, et al. Outcomes after endovascular treatment of symptomatic patients with Takayasu's arteritis. Interv Neuroradiol. 2011; 17(2): 252–260.
  15. Khandelwal N, Kalra N, Garg MK, et al. Multidetector CT angiography in Takayasu arteritis. Eur J Radiol. 2011; 77(2): 369–374.
  16. Dagna L, Salvo F, Tiraboschi M, et al. Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med. 2011; 155(7): 425–433.
  17. Bali HK, Jain S, Jain A, et al. Stent supported angioplasty in Takayasu arteritis. International Journal of Cardiology. 1998; 66: S213–S217.
  18. Colyer JH, Ratnayaka K, Slack MC, et al. Renal artery stenosis in children: therapeutic percutaneous balloon and stent angioplasty. Pediatr Nephrol. 2014; 29(6): 1067–1074.
  19. Zhu G, He F, Gu Y, et al. Angioplasty for pediatric renovascular hypertension: a 13-year experience. Diagn Interv Radiol. 2014; 20(3): 285–292.
  20. Shroff R, Roebuck DJ, Gordon I, et al. Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics. 2006; 118(1): 268–275.
  21. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000; 216(1): 78–85.
  22. Dudek D, Onuma Y, Ormiston JA, et al. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention. 2012; 7(9): 1060–1061.
  23. Ahn J, Park SH, Shin WY, et al. Use of drug-eluting stent with provisional T-stenting technique in the treatment of renal artery bifurcation stenosis; long-term angiographic follow-up. J Korean Med Sci. 2011; 26(11): 1512–1514.
  24. Wheatley K, Ives N, Gray R, et al. ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009; 361(20): 1953–1962.
  25. Cooper CJ, Murphy TP, Cutlip DE, et al. CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014; 370(1): 13–22.